|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
AU2009322393B2
(en)
*
|
2008-12-03 |
2017-02-02 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of HCV NS5A
|
|
CN102264737A
(zh)
*
|
2008-12-23 |
2011-11-30 |
雅培制药有限公司 |
抗病毒化合物
|
|
RU2505539C2
(ru)
|
2008-12-23 |
2014-01-27 |
Эбботт Лэборетриз |
Антивирусные соединения
|
|
US8314135B2
(en)
|
2009-02-09 |
2012-11-20 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole antivirals
|
|
US8188132B2
(en)
|
2009-02-17 |
2012-05-29 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
US8637561B2
(en)
*
|
2009-02-17 |
2014-01-28 |
Enanta Pharmaceuticals, Inc. |
Linked diimidazole derivatives
|
|
US8242156B2
(en)
|
2009-02-17 |
2012-08-14 |
Enanta Pharmaceuticals, Inc. |
Linked dibenzimidazole derivatives
|
|
US8420686B2
(en)
|
2009-02-17 |
2013-04-16 |
Enanta Pharmaceuticals, Inc. |
Linked diimidazole antivirals
|
|
US8394968B2
(en)
|
2009-02-17 |
2013-03-12 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
TWI438200B
(zh)
|
2009-02-17 |
2014-05-21 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
|
US8673954B2
(en)
|
2009-02-27 |
2014-03-18 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
US9765087B2
(en)
|
2009-02-27 |
2017-09-19 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
US8101643B2
(en)
|
2009-02-27 |
2012-01-24 |
Enanta Pharmaceuticals, Inc. |
Benzimidazole derivatives
|
|
SG174146A1
(en)
*
|
2009-02-27 |
2011-10-28 |
Enanta Pharm Inc |
Hepatitis c virus inhibitors
|
|
AU2013204195B2
(en)
*
|
2009-02-27 |
2016-09-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8426458B2
(en)
*
|
2009-02-27 |
2013-04-23 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C Virus inhibitors
|
|
US8507522B2
(en)
*
|
2009-03-06 |
2013-08-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8709999B2
(en)
|
2009-03-27 |
2014-04-29 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic HCV inhibitors
|
|
TWI476190B
(zh)
*
|
2009-03-30 |
2015-03-11 |
必治妥美雅史谷比公司 |
C型肝炎病毒抑制劑
|
|
US8796466B2
(en)
|
2009-03-30 |
2014-08-05 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
TW201038559A
(en)
|
2009-04-09 |
2010-11-01 |
Bristol Myers Squibb Co |
Hepatitis C virus inhibitors
|
|
US8143414B2
(en)
|
2009-04-13 |
2012-03-27 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
WO2010120935A1
(en)
*
|
2009-04-15 |
2010-10-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
AU2010249080A1
(en)
|
2009-05-12 |
2012-01-12 |
Merck Sharp & Dohme Corp. |
Fused tricyclic aryl compounds useful for the treatment of viral diseases
|
|
SG176015A1
(en)
*
|
2009-05-13 |
2011-12-29 |
Gilead Sciences Inc |
Antiviral compounds
|
|
US8211928B2
(en)
|
2009-05-29 |
2012-07-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
EP2435421A1
(en)
*
|
2009-05-29 |
2012-04-04 |
Schering Corporation |
Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
|
|
US8138215B2
(en)
|
2009-05-29 |
2012-03-20 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
JP2012528195A
(ja)
*
|
2009-05-29 |
2012-11-12 |
メルク・シャープ・アンド・ドーム・コーポレーション |
C型肝炎などの疾患を処置するための3つの結合アリール部分で構成された抗菌性化合物
|
|
US9394279B2
(en)
|
2009-06-11 |
2016-07-19 |
Abbvie Inc. |
Anti-viral compounds
|
|
US8716454B2
(en)
|
2009-06-11 |
2014-05-06 |
Abbvie Inc. |
Solid compositions
|
|
US8937150B2
(en)
|
2009-06-11 |
2015-01-20 |
Abbvie Inc. |
Anti-viral compounds
|
|
EP2853531A3
(en)
|
2009-06-11 |
2015-08-12 |
AbbVie Bahamas Ltd. |
Antiviral compounds
|
|
US8221737B2
(en)
|
2009-06-16 |
2012-07-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8609648B2
(en)
|
2009-07-02 |
2013-12-17 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8354419B2
(en)
|
2009-07-16 |
2013-01-15 |
Vertex Pharmaceuticals Incorporated |
Benzimidazole analogues for the treatment or prevention of flavivirus infections
|
|
KR20120051022A
(ko)
|
2009-07-21 |
2012-05-21 |
길리애드 사이언시즈, 인코포레이티드 |
플라비비리데 바이러스의억제제
|
|
EP2462135A1
(en)
|
2009-08-07 |
2012-06-13 |
Janssen R&D Ireland |
Bis-benzimidazole derivatives as hepatitis c virus inhibitors
|
|
CA2768637A1
(en)
|
2009-08-07 |
2011-02-10 |
Tibotec Pharmaceuticals |
Phenyl ethynyl derivatives as hepatitis c virus inhibitors
|
|
CN102482260A
(zh)
|
2009-09-03 |
2012-05-30 |
泰博特克药品公司 |
双-苯并咪唑衍生物
|
|
EP2473056A4
(en)
|
2009-09-04 |
2013-02-13 |
Glaxosmithkline Llc |
CHEMICAL COMPOUNDS
|
|
CA2771124C
(en)
|
2009-09-09 |
2019-01-15 |
Gilead Sciences, Inc. |
Inhibitors of flaviviridae viruses
|
|
US8927709B2
(en)
|
2009-09-11 |
2015-01-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8822700B2
(en)
|
2009-09-11 |
2014-09-02 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8759332B2
(en)
|
2009-09-11 |
2014-06-24 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
EP2475254A4
(en)
*
|
2009-09-11 |
2013-05-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
US8815928B2
(en)
|
2009-09-11 |
2014-08-26 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8703938B2
(en)
|
2009-09-11 |
2014-04-22 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
WO2011031904A1
(en)
|
2009-09-11 |
2011-03-17 |
Enanta Pharmaceuticals, Inc |
Hepatitis c virus inhibitors
|
|
UA108211C2
(uk)
*
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
|
US20110269956A1
(en)
*
|
2009-11-11 |
2011-11-03 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20110274648A1
(en)
*
|
2009-11-11 |
2011-11-10 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US20110281910A1
(en)
*
|
2009-11-12 |
2011-11-17 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US8653070B2
(en)
|
2009-12-14 |
2014-02-18 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
US8377980B2
(en)
|
2009-12-16 |
2013-02-19 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CN102791687B
(zh)
*
|
2009-12-18 |
2015-02-11 |
北京凯因科技股份有限公司 |
C型肝炎病毒复制的新型抑制剂
|
|
MY159958A
(en)
|
2009-12-18 |
2017-02-15 |
Idenix Pharmaceuticals Inc |
5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
|
|
WO2011087740A1
(en)
|
2009-12-22 |
2011-07-21 |
Schering Corporation |
Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases
|
|
CN102883718A
(zh)
*
|
2009-12-24 |
2013-01-16 |
顶点制药公司 |
用于治疗或预防黄病毒感染的类似物
|
|
US8362020B2
(en)
|
2009-12-30 |
2013-01-29 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
TWI491609B
(zh)
|
2010-01-15 |
2015-07-11 |
Gilead Sciences Inc |
黃熱病毒科(Flaviviridae)病毒之抑制劑類
|
|
EA201290575A1
(ru)
|
2010-01-15 |
2013-01-30 |
Джилид Сайэнс, Инк. |
Ингибиторы вирусов flaviviridae
|
|
US8933110B2
(en)
|
2010-01-25 |
2015-01-13 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
EA201201031A1
(ru)
|
2010-01-25 |
2013-02-28 |
Энанта Фармасьютиклз, Инк. |
Ингибиторы вируса гепатита с
|
|
US8623814B2
(en)
|
2010-02-23 |
2014-01-07 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
US8178531B2
(en)
|
2010-02-23 |
2012-05-15 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
WO2011109037A1
(en)
|
2010-03-04 |
2011-09-09 |
Enanta Pharmaceuticals, Inc. |
Combination pharmaceutical agents as inhibitors of hcv replication
|
|
MA34147B1
(fr)
|
2010-03-09 |
2013-04-03 |
Merck Sharp & Dohme |
Composes tricycliques fusionnes de silyle et leurs methodes d'utilisation dans le cadre du traitement de maladies virales
|
|
TW201141857A
(en)
*
|
2010-03-24 |
2011-12-01 |
Vertex Pharma |
Analogues for the treatment or prevention of flavivirus infections
|
|
WO2011119853A1
(en)
|
2010-03-24 |
2011-09-29 |
Vertex Pharmaceuticals Incorporated |
Analogues for the treatment or prevention of flavivirus infections
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
US9127021B2
(en)
|
2010-04-09 |
2015-09-08 |
Enanta Pharmaceuticals, Inc. |
Hepatitis C virus inhibitors
|
|
RU2569678C2
(ru)
|
2010-04-22 |
2015-11-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ получения циклоалкилкарбоксамидо-индольных соединений
|
|
EP2575475A4
(en)
*
|
2010-05-28 |
2013-11-27 |
Presidio Pharmaceuticals Inc |
HCV NS5A INHIBITORS
|
|
EP2575819A4
(en)
|
2010-06-04 |
2013-11-27 |
Enanta Pharm Inc |
INHIBITORS OF HEPATITIS C VIRUS
|
|
CA2802067A1
(en)
*
|
2010-06-09 |
2011-12-15 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of hcv ns5a protein
|
|
NZ605440A
(en)
|
2010-06-10 |
2014-05-30 |
Abbvie Bahamas Ltd |
Solid compositions comprising an hcv inhibitor
|
|
JP2013531011A
(ja)
|
2010-06-28 |
2013-08-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
フラビウイルス感染の処置または予防のための化合物および方法
|
|
JP2013529684A
(ja)
|
2010-06-28 |
2013-07-22 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
フラビウイルス感染の処置または予防のための化合物および方法
|
|
CA2805440A1
(en)
|
2010-07-26 |
2012-02-09 |
Merck Sharp & Dohme Corp. |
Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
|
|
AU2011284857B2
(en)
|
2010-07-26 |
2014-07-24 |
Janssen Sciences Ireland Uc |
Hetero-bicyclic derivatives as HCV inhibitors
|
|
KR20140045903A
(ko)
*
|
2010-08-04 |
2014-04-17 |
브리스톨-마이어스 스큅 컴퍼니 |
C형 간염 바이러스 억제제
|
|
EP2603080A4
(en)
|
2010-08-12 |
2014-01-22 |
Enanta Pharm Inc |
HEPATITIS C-VIRUS HEMMER
|
|
CA2808291A1
(en)
|
2010-08-17 |
2012-02-23 |
Vertex Pharmaceuticals Incorporated |
Compounds and methods for the treatment or prevention of flaviviridae viral infections
|
|
BR112013004520A2
(pt)
|
2010-08-26 |
2016-06-07 |
Univ Emory |
inibidores potentes e seletivos do virus da hepatite c
|
|
US8822520B2
(en)
|
2010-09-22 |
2014-09-02 |
Presidio Pharmaceuticals, Inc. |
Substituted bicyclic HCV inhibitors
|
|
MX2013002927A
(es)
*
|
2010-09-24 |
2013-05-30 |
Bristol Myers Squibb Co |
Inhibidores del virus de la hepatitis c.
|
|
EP2621279B1
(en)
|
2010-09-29 |
2018-04-04 |
Merck Sharp & Dohme Corp. |
Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
|
|
US8999967B2
(en)
|
2010-09-29 |
2015-04-07 |
Presidio Pharmaceuticals, Inc. |
Tricyclic fused ring inhibitors of hepatitis C
|
|
BR112013007696A2
(pt)
*
|
2010-09-29 |
2019-09-24 |
Merck Sharp & Dohme |
composto, composição farmacêutica, usos do referido composto e da referida composição
|
|
CN103459399A
(zh)
*
|
2010-09-29 |
2013-12-18 |
默沙东公司 |
用于治疗丙型肝炎病毒感染的四环吲哚衍生物
|
|
AU2014203655B2
(en)
*
|
2010-10-13 |
2016-07-07 |
Abbvie Ireland Unlimited Company |
Anti-viral compounds
|
|
TWI621611B
(zh)
*
|
2010-10-13 |
2018-04-21 |
艾伯維愛爾蘭無限公司 |
抗病毒化合物
|
|
CN103269586B
(zh)
|
2010-10-26 |
2015-07-15 |
普雷西迪奥制药公司 |
丙型肝炎病毒抑制剂
|
|
CA2814534A1
(en)
|
2010-11-04 |
2012-05-10 |
Theravance, Inc. |
Novel inhibitors of hepatitis c virus
|
|
KR101835474B1
(ko)
*
|
2010-11-17 |
2018-03-08 |
길리애드 파마셋 엘엘씨 |
항바이러스 화합물
|
|
RU2452735C1
(ru)
*
|
2010-11-30 |
2012-06-10 |
Александр Васильевич Иващенко |
Замещенные азолы, противовирусный активный компонент, фармацевтическая композиция, способ получения и применения
|
|
EP2651925A4
(en)
*
|
2010-12-15 |
2014-06-18 |
Abbvie Inc |
ANTI-VIRAL COMPOUNDS
|
|
WO2012083048A2
(en)
*
|
2010-12-15 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
US20140364616A1
(en)
*
|
2010-12-15 |
2014-12-11 |
Abbvie Inc. |
Anti-viral compounds
|
|
US20150031884A1
(en)
*
|
2010-12-15 |
2015-01-29 |
Abbvie Inc. |
Anti-viral compounds
|
|
WO2012083170A1
(en)
*
|
2010-12-16 |
2012-06-21 |
Abbott Laboratories |
Anti-viral compounds
|
|
WO2012087976A2
(en)
*
|
2010-12-21 |
2012-06-28 |
Intermune, Inc. |
Novel inhibitors of hepatitis c virus replication
|
|
JP5931744B2
(ja)
*
|
2010-12-29 |
2016-06-08 |
キッセイ薬品工業株式会社 |
アセチレン誘導体及びその医薬用途
|
|
US8552047B2
(en)
|
2011-02-07 |
2013-10-08 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US9546160B2
(en)
|
2011-05-12 |
2017-01-17 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US10201584B1
(en)
|
2011-05-17 |
2019-02-12 |
Abbvie Inc. |
Compositions and methods for treating HCV
|
|
WO2012158861A2
(en)
|
2011-05-18 |
2012-11-22 |
Enanta Pharmaceuticals, Inc. |
Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives
|
|
US8741946B2
(en)
|
2011-07-13 |
2014-06-03 |
Gilead Sciences, Inc. |
Inhibitors of flaviviridae viruses
|
|
WO2013016499A1
(en)
|
2011-07-26 |
2013-01-31 |
Vertex Pharmaceuticals Incorporated |
Methods for preparation of thiophene compounds
|
|
WO2013016491A1
(en)
|
2011-07-26 |
2013-01-31 |
Vertex Pharmaceuticals Incorporated |
Thiophene compounds
|
|
WO2013030750A1
(en)
|
2011-09-01 |
2013-03-07 |
Lupin Limited |
Antiviral compounds
|
|
US20140378416A1
(en)
|
2011-09-14 |
2014-12-25 |
Michael P. Dwyer |
Silyl-containing heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
|
HRP20180237T4
(hr)
|
2011-09-16 |
2020-12-11 |
Gilead Pharmasset Llc |
Metode za liječenje hcv-a
|
|
US20130164260A1
(en)
|
2011-11-16 |
2013-06-27 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
CN103987723B
(zh)
*
|
2011-12-16 |
2017-03-01 |
弗·哈夫曼-拉罗切有限公司 |
Hcv ns5a 的抑制剂
|
|
MX340033B
(es)
*
|
2011-12-28 |
2016-06-21 |
Janssen Sciences Ireland Uc |
Derivados heterobiciclicos como inhibidores del virus de la hepatitis c.
|
|
AU2012360910B8
(en)
|
2011-12-28 |
2017-02-02 |
Janssen Sciences Ireland Uc |
Quinazolinone derivatives as HCV inhibitors
|
|
US9034832B2
(en)
|
2011-12-29 |
2015-05-19 |
Abbvie Inc. |
Solid compositions
|
|
US9326973B2
(en)
|
2012-01-13 |
2016-05-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
US9073943B2
(en)
|
2012-02-10 |
2015-07-07 |
Lupin Limited |
Antiviral compounds with a dibenzooxaheterocycle moiety
|
|
NZ630805A
(en)
|
2012-03-22 |
2016-01-29 |
Alios Biopharma Inc |
Pharmaceutical combinations comprising a thionucleotide analog
|
|
WO2013157540A1
(ja)
|
2012-04-17 |
2013-10-24 |
富士フイルム株式会社 |
含窒素複素環化合物またはその塩
|
|
US20130309196A1
(en)
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
TWI610916B
(zh)
|
2012-08-03 |
2018-01-11 |
廣東東陽光藥業有限公司 |
作爲丙型肝炎抑制劑的橋環化合物及其在藥物中的應用
|
|
US8759544B2
(en)
|
2012-08-17 |
2014-06-24 |
Gilead Sciences, Inc. |
Synthesis of an antiviral compound
|
|
US8841340B2
(en)
|
2012-08-17 |
2014-09-23 |
Gilead Sciences, Inc. |
Solid forms of an antiviral compound
|
|
US8927741B2
(en)
|
2012-08-17 |
2015-01-06 |
Gilead Sciences, Inc. |
Synthesis of an antiviral compound
|
|
US9416139B2
(en)
|
2012-11-29 |
2016-08-16 |
Sunshine Lake Pharma Co., Ltd. |
Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof
|
|
WO2014082380A1
(en)
|
2012-11-29 |
2014-06-05 |
Sunshine Lake Pharma Co., Ltd. |
Fused ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
|
|
CN103880823B
(zh)
*
|
2012-12-21 |
2017-12-05 |
广东东阳光药业有限公司 |
作为丙型肝炎抑制剂的螺环化合物及其在药物中的应用
|
|
EP2950786B1
(en)
|
2013-01-31 |
2019-11-27 |
Gilead Pharmasset LLC |
Combination formulation of two antiviral compounds
|
|
RU2507201C1
(ru)
|
2013-02-07 |
2014-02-20 |
Александр Васильевич Иващенко |
Алкил [(s)-1-((s)-2-{5-[4-(4-{2-[(s)-1-((s)-2-метоксикарбониламино-3-метил-бутирил)-пирролидин-2-ил]-3н-имидазол-4-ил}-бута-1,3-диинил)-фенил]-1н-имидазол-2-ил}-пирролидин-1-карбонил)-2-метил-пропил]-карбамат нафталин-1,5-дисульфонат, фармацевтическая композиция, лекарственное средство, способ лечения вирусных заболеваний
|
|
US20150065439A1
(en)
|
2013-02-28 |
2015-03-05 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical compositions
|
|
US11484534B2
(en)
|
2013-03-14 |
2022-11-01 |
Abbvie Inc. |
Methods for treating HCV
|
|
US20150023913A1
(en)
|
2013-07-02 |
2015-01-22 |
Bristol-Myers Squibb Company |
Hepatitis C Virus Inhibitors
|
|
US9717712B2
(en)
|
2013-07-02 |
2017-08-01 |
Bristol-Myers Squibb Company |
Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus
|
|
JP2016527232A
(ja)
|
2013-07-17 |
2016-09-08 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
Hcvの治療に使用するためのビフェニル誘導体を含む組み合わせ
|
|
EA201690473A1
(ru)
|
2013-08-27 |
2017-03-31 |
ГАЙЛИД ФАРМАССЕТ ЭлЭлСи |
Комбинированный состав двух противовирусных соединений
|
|
WO2015065817A1
(en)
|
2013-10-30 |
2015-05-07 |
Merck Sharp & Dohme Corp. |
Pseudopolymorphs of an hcv ns5a inhibitor and uses thereof
|
|
WO2015089810A1
(en)
|
2013-12-20 |
2015-06-25 |
Merck Sharp & Dohme Corp. |
Fused tetracyclic heterocyclic compounds and methods of use thereof for the treatment of viral diseases
|
|
CN103664581B
(zh)
*
|
2013-12-20 |
2016-07-06 |
中节能万润股份有限公司 |
一种反,反-4,4’-二环己基二甲酸的制备方法
|
|
WO2015103490A1
(en)
|
2014-01-03 |
2015-07-09 |
Abbvie, Inc. |
Solid antiviral dosage forms
|
|
WO2015110048A1
(en)
|
2014-01-23 |
2015-07-30 |
Sunshine Lake Pharma Co., Ltd. |
Bridged ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
|
|
PL3925607T5
(pl)
|
2014-04-15 |
2026-06-01 |
Vertex Pharmaceuticals Incorporated |
Kompozycje farmaceutyczne do leczenia chorób, w których pośredniczy mukowiscydozowy przezbłonowy regulator przewodnictwa
|
|
CN105175408B
(zh)
*
|
2014-06-04 |
2018-07-17 |
中国人民解放军第二军医大学 |
苯并噻唑类化合物及其作为药物的用途
|
|
TWI721947B
(zh)
|
2014-06-11 |
2021-03-21 |
美商基利法瑪席特有限責任公司 |
抗病毒化合物的固態形式
|
|
GB201506660D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
GB201506658D0
(en)
|
2015-04-20 |
2015-06-03 |
Cellcentric Ltd |
Pharmaceutical compounds
|
|
US10617675B2
(en)
|
2015-08-06 |
2020-04-14 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
CN106279117A
(zh)
*
|
2016-08-16 |
2017-01-04 |
上海同昌生物医药科技有限公司 |
一种雷迪帕韦中间体的合成方法及其产品
|
|
WO2018032467A1
(en)
|
2016-08-18 |
2018-02-22 |
Merck Sharp & Dohme Corp. |
Chromane-substitued tetracyclic compounds and uses thereof for treatment of viral diseases
|
|
WO2018032468A1
(en)
|
2016-08-18 |
2018-02-22 |
Merck Sharp & Dohme Corp. |
Heterocycle-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases
|
|
CN108727345B
(zh)
*
|
2017-04-25 |
2023-06-27 |
广东东阳光药业有限公司 |
一种咪唑环中间体的制备方法
|
|
US20220099637A1
(en)
|
2018-12-04 |
2022-03-31 |
Bristol-Myers Squibb Company |
Methods of analysis using in-sample calibration curve by multiple isotopologue reaction monitoring
|
|
WO2021138391A1
(en)
|
2019-12-30 |
2021-07-08 |
Tyra Biosciences, Inc. |
Indazole compounds
|
|
AU2021275118A1
(en)
|
2020-05-22 |
2022-12-01 |
Aligos Therapeutics, Inc. |
Methods and compositions for targeting PD-L1
|
|
MX2023007793A
(es)
|
2020-12-30 |
2023-09-22 |
Tyra Biosciences Inc |
Compuestos de indazol como inhibidores de cinasas.
|
|
JP7723119B2
(ja)
|
2021-05-21 |
2025-08-13 |
ギリアード サイエンシーズ, インコーポレイテッド |
ジカウイルス感染症の治療のための四環系化合物
|
|
AU2022279234B2
(en)
|
2021-05-21 |
2025-08-28 |
Gilead Sciences, Inc. |
Pentacyclic derivatives as zika virus inhibitors
|
|
MX2023014819A
(es)
|
2021-06-14 |
2024-03-21 |
Scorpion Therapeutics Inc |
Derivados de la urea que pueden ser utilizados para tratar el cancer.
|